Incidence and Risk Factors of Venous Thromboembolism in Patients
with Lung Adenocarcinoma Receiving Anti-tumor Therapy.
10.3779/j.issn.1009-3419.2023.102.22
- Author:
Xing CHEN
1
;
Weiping XIE
1
;
Chaoli YUE
1
;
Ting TANG
1
;
Yuchuyuan SUN
1
;
Kouying LIU
1
Author Information
1. Department of Respiratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Publication Type:Journal Article
- Keywords:
Antitumor therapy;
Lung neoplasms;
Risk factors;
Venous thromboembolism
- MeSH:
Humans;
Venous Thromboembolism;
Incidence;
Lung Neoplasms;
Adenocarcinoma of Lung;
Risk Factors
- From:
Chinese Journal of Lung Cancer
2023;26(6):439-448
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Venous thromboembolism (VTE) as the most common cancer-associated complication has become the second death-causing reason among cancer patients. The management of VTE in patients with lung adenocarcinoma should focus on early and timely detection of risk factors. The aim of the study is to investigate the current situation of VTE in patients with lung adenocarcinoma treated with anti-tumor therapy and then explore the risk factors associated with the occurrence of VTE during anti-tumor therapy for early detection and screening of VTE.
METHODS:The present study included patients diagnosed as lung adenocarcinoma undergoing anti-tumor therapy in First Affiliated Hospital of Nanjing Medical University between December 2019 and May 2021. The risk factors were identified via univariate and multivariate Cox analysis. The incidence of independent risk factors were investigated through Kaplan-Meier curves combined with Log-rank test.
RESULTS:The results of univariate and multivariate Cox regression showed that history of VTE, targeted therapy and radiotherapy were risk factors for VTE in patients with lung adenocarcinoma treated with anti-tumor therapy (P<0.05). Furthermore, the results of Kaplan-Meier curves and Log-rank tests indicated the incidences of VTE in patients with history of VTE, targeted therapy and radiotherapy were higher (P<0.05).
CONCLUSIONS:History of VTE, radiotherapy and targeted therapy are found as independent risk factors for the occurrence of VTE, which should be identified and monitored for reduction of VTE incidence.
.
